Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China
· Delayed Price · Currency is CNY 4.000
-0.030 (-0.74%)
Mar 11, 2026, 3:00 PM CST
SHA:600594 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,161 | 2,801 | 4,506 | 4,379 | 6,438 | 4,134 | Upgrade
|
| Market Cap Growth | 10.06% | -37.83% | 2.89% | -31.98% | 55.75% | 4.82% | Upgrade
|
| Enterprise Value | 3,546 | 3,175 | 4,946 | 5,009 | 6,897 | 4,861 | Upgrade
|
| Last Close Price | 4.03 | 3.56 | 5.57 | 5.41 | 7.96 | 5.00 | Upgrade
|
| PE Ratio | - | - | 43.58 | - | 26.41 | 18.07 | Upgrade
|
| Forward PE | - | 19.12 | 19.12 | 19.12 | 19.12 | 19.12 | Upgrade
|
| PS Ratio | 1.66 | 1.29 | 1.60 | 1.60 | 1.92 | 1.21 | Upgrade
|
| PB Ratio | 1.26 | 1.08 | 1.49 | 1.37 | 1.81 | 1.19 | Upgrade
|
| P/TBV Ratio | 1.61 | 1.37 | 1.89 | 1.74 | 2.74 | 1.73 | Upgrade
|
| P/FCF Ratio | 74.60 | - | 18.23 | 195.73 | 13.24 | - | Upgrade
|
| P/OCF Ratio | 34.79 | 32.25 | 11.93 | 12.68 | 6.89 | 11.27 | Upgrade
|
| EV/Sales Ratio | 1.86 | 1.46 | 1.75 | 1.83 | 2.06 | 1.42 | Upgrade
|
| EV/EBITDA Ratio | - | - | 14.75 | 11.89 | 11.88 | 8.00 | Upgrade
|
| EV/EBIT Ratio | - | - | 34.40 | 20.08 | 15.92 | 10.42 | Upgrade
|
| EV/FCF Ratio | 83.68 | - | 20.01 | 223.87 | 14.18 | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.37 | 0.33 | 0.34 | 0.26 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 2.88 | 2.52 | 1.56 | 1.97 | Upgrade
|
| Debt / FCF Ratio | 20.44 | - | 4.01 | 48.58 | 1.88 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.16 | 0.10 | 0.16 | 0.15 | 0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -23.98 | -5.47 | 0.87 | 1.17 | 0.92 | 0.78 | Upgrade
|
| Net Debt / FCF Ratio | 6.43 | -43.49 | 1.19 | 22.11 | 1.10 | -16.36 | Upgrade
|
| Asset Turnover | 0.48 | 0.50 | 0.60 | 0.55 | 0.65 | 0.63 | Upgrade
|
| Inventory Turnover | 1.42 | 1.43 | 1.54 | 1.38 | 1.42 | 1.58 | Upgrade
|
| Quick Ratio | 1.16 | 1.17 | 1.56 | 1.17 | 1.03 | 1.13 | Upgrade
|
| Current Ratio | 1.88 | 1.84 | 2.23 | 1.74 | 1.59 | 1.49 | Upgrade
|
| Return on Equity (ROE) | -9.49% | -11.90% | 2.94% | -12.98% | 6.57% | 5.88% | Upgrade
|
| Return on Assets (ROA) | -2.96% | -3.72% | 1.90% | 3.14% | 5.26% | 5.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.72% | -8.18% | 2.84% | 6.41% | 8.02% | 8.35% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.40% | -8.20% | 3.90% | 6.70% | 10.90% | 12.60% | Upgrade
|
| Earnings Yield | -7.42% | -11.32% | 2.30% | -9.74% | 3.79% | 5.53% | Upgrade
|
| FCF Yield | 1.34% | -0.34% | 5.49% | 0.51% | 7.56% | -0.70% | Upgrade
|
| Dividend Yield | - | - | 1.19% | - | - | 8.60% | Upgrade
|
| Payout Ratio | - | - | 39.82% | - | 62.40% | 240.08% | Upgrade
|
| Buyback Yield / Dilution | 0.39% | 0.03% | 0.41% | -0.14% | 0.01% | 0.15% | Upgrade
|
| Total Shareholder Return | 0.39% | 0.03% | 1.59% | -0.14% | 0.01% | 8.75% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.